Clinical trial
Migraine Prevention Using Pulsed Shortwave Therapy
NCT03166046 is registered in ClinicalTrials.gov with BioElectronics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Migraine Prevention Using Pulsed Shortwave Therapy
- Lead sponsor
- BioElectronics Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- April 30, 2018
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine